SonoSite Begins Customer Shipments of S Series Point-of-Care Ultrasound Tools
17 December 2007 - 9:30PM
Business Wire
SonoSite, Inc. (Nasdaq:SONO), the world leader in point-of-care,
hand-carried ultrasound, today announced that it has begun
worldwide shipments of its S Series� ultrasound tools. Based on the
company�s fourth generation technology platform, the S Series
product line combines the processing power, image quality and
advanced data management features of SonoSite�s newly introduced
M-Turbo� system with a customized user interface to address the
specific needs of four clinical specialties. �SonoSite is the only
company that has designed a system that can withstand rigorous use
in the Intensive Care Unit (ICU),� said John M. Oropello, MD, FCCP,
FCCM, Professor of Surgery and Medicine, Program Director, Critical
Care Medicine and Co-Director, Neurosurgical � ICU, Mount Sinai
School of Medicine, New York. �We evaluated a lot of machines and
no one else has taken into account what critical care physicians
need. Both the S-ICU and M-Turbo have superb image quality and are
easy to clean�so essential to infection control. I can foresee the
day when there will be an S ultrasound tool mounted by every
bedside in the ICU.� Receiving one of the first S Series units
shipped internationally is Sir Charles Gairdner Hospital of Perth,
Australia. �The S-Nerve offers a sleek, elegant design with a very
simple user interface,� said Consultant Anaesthetist, Dr. Graham
Hocking, MBChB, DMCC, FRCA, FFPMANZCA. �My students were finding
their way around it in no time, freeing all of their concentration
for scanning.� The S Series product line includes the S-FAST� for
emergency medicine physicians, the S-Nerve� for anesthesiologists,
the S-Cath� for interventionalists and the S-ICU� for intensivists.
Like SonoSite�s M-Turbo system, which the company began shipping on
December 5, the S Series devices deliver breakthrough image clarity
and seamless connectivity for digital image export in a rugged,
hand-carried product that can be mounted on a pole, wall or ceiling
for zero footprint. Formally introduced in October 2007 at medical
meetings and congresses, physicians have enthusiastically responded
to the following features of the M-Turbo and S Series products:
Outstanding Image Quality � The M-Turbo system and S Series devices
advanced processing power is 16x more powerful than its industry
leading MicroMaxx� system, and utilizes the new, advanced
SonoADAPT�, SonoHD�, and SonoMB� technologies for dramatic
improvements in image quality; State-of-the-Art Connectivity �
SonoSite engineers worked with Texas Instruments to integrate its
DaVinci� technology and Microsoft to integrate its Windows Embedded
CE 6.0 operating system for seamless data transfer and
connectivity. Clinicians can export images easily from the new
products to a USB storage device in standard PC formats�MPEG4
(H.264), JPEG, HTML and BMP�for review or storage on PC or Mac�
computers; Unmatched Commitment to Clinical Education � The
Education Key� program, new with the S Series devices and the
M-Turbo system, is a USB thumb drive that contains a combination of
system operation video tutorials, application-specific video
refresher programs that provide peer-to-peer instruction on how to
perform specific exams and procedures, and an image reference
library of application specific sonographic anatomy for comparison
purposes; Designed for Point-of-Care Demands � Like SonoSite�s
earlier products, the M-Turbo and S Series, and their transducers
are designed to withstand a 3-foot drop onto a hard surface, have
sealed surfaces that can be wiped down with disinfectant and boot
within seconds of a cold start; and Landmark Warranty � The M-Turbo
and S Series products and transducers carry the same, unprecedented
5-year warranty that SonoSite introduced with the launch of the
MicroMaxx system in 2005. About SonoSite SonoSite, Inc.
(www.sonosite.com) is the innovator and world leader in
hand-carried ultrasound. Headquartered near Seattle, the company is
represented by ten subsidiaries and a global distribution network
in over 90 countries. SonoSite�s small, lightweight systems are
expanding the use of ultrasound across the clinical spectrum by
cost-effectively bringing high performance ultrasound to the point
of patient care. The company employs over 600 people worldwide.
Forward-looking Information and the Private Litigation Reform Act
of 1995 Certain statements in this press release relating to the
market acceptance of our products, possible future sales relating
to expected orders, and our future financial position and operating
results are �forward-looking statements� for the purposes of the
safe harbor provisions of the Private Securities Litigation Reform
Act of 1995. These forward-looking statements are based on the
opinions and estimates of our management at the time the statements
are made and are subject to risks and uncertainties that could
cause actual results to differ materially from those expected or
implied by the forward-looking statements. These statements are not
guaranties of future performance and are subject to known and
unknown risks and uncertainties and are based on potentially
inaccurate assumptions. Factors that could affect the rate and
extent of market acceptance of our products, the receipt of
expected orders, and our financial performance include our ability
to successfully manufacture, market and sell our ultrasound
systems, our ability to accurately forecast customer demand for our
products, our ability to manufacture and ship our systems in a
timely manner to meet customer demand, variability in quarterly
results caused by the timing of large project orders from
governmental or international entities and the seasonality of
hospital purchasing patterns, timely receipts of regulatory
approvals to market and sell our products, regulatory and
reimbursement changes in various national health care markets,
constraints in government and public health spending, the ability
of our distribution partners and other sales channels such as the
physician office sales force to market and sell our products, the
impact of patent litigation, our ability to execute our acquisition
strategy, the effect of transactions and activities associated with
our issuance of senior convertible debt in July 2007 on the market
price of our common stock, and as well as other factors contained
in the Item 1A. �Risk Factors� section of our most recent Annual
Report on Form 10-K, as updated by our most recent quarterly
reports filed on Form 10-Q filed with the Securities and Exchange
Commission. We caution readers not to place undue reliance upon
these forward-looking statements that speak only as to the date of
this release. We undertake no obligation to publicly revise any
forward-looking statements to reflect new information, events or
circumstances after the date of this release or to reflect the
occurrence of unanticipated events.
Sonos (NASDAQ:SONO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sonos (NASDAQ:SONO)
Historical Stock Chart
From Jul 2023 to Jul 2024